1.
Murray KF,
Carithers RL.
AASLD practice guidelines: Evaluation of the patient for liver transplantation.
Hepatology.
1 de junio de 2005;41(6):1407-32.
2.
Faisal N,
Bilodeau M,
Aljudaibi B,
Hirsch G,
Yoshida EM,
Hussaini T,
et al.
Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter «Real-Life» Experience.
Transplantation.
mayo de 2016;100(5):1059-65.
3.
Bellido-Muñoz F,
Giráldez-Gallego A,
Roca-Oporto C,
GarcĂa-Cayuela T,
Pascasio-Acevedo JM,
Sousa-MartĂn JM.
Monitoring the Natural Evolution and Response to Treatment of Post Liver Transplant Recurrent Hepatitis C Using Transient Elastography: Preliminary Results.
Transplant Proc.
septiembre de 2012;44(7):2082-6.
4.
Crespo G,
Gambato M,
Millán O,
Casals G,
Ruiz P,
Londoño MC,
et al.
Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation.
Transpl Infect Dis Off J Transplant Soc.
junio de 2016;18(3):471-9.
5.
Caiado AHM,
Blasbalg R,
Marcelino ASZ,
da Cunha Pinho M,
Chammas MC,
da Costa Leite C,
et al.
Complications of liver transplantation: multimodality imaging approach.
Radiogr Rev Publ Radiol Soc N Am Inc.
octubre de 2007;27(5):1401-17.
6.Fierbinteanu-Braticevici C.
Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis.
World J Gastroenterol.
2009;15(44):5525.
7.
Kwo PY.
Direct acting antiviral therapy after liver transplantation.
Curr Opin Gastroenterol.
mayo de 2016;32(3):152-8.
8.
Righi E,
Londero A,
Carnelutti A,
Baccarani U,
Bassetti M.
Impact of new treatment options for hepatitis C virus infection in liver transplantation.
World J Gastroenterol WJG.
14 de octubre de 2015;21(38):10760-75.
9.
Jackson WE,
Hanouneh M,
Apfel T,
Alkhouri N,
John BV,
Zervos X,
et al.
Sofosbuvir and simeprevir without ribavirin effectively treat hepatitis C virus genotype 1 infection after liver transplantation in a two-center experience.
Clin Transplant.
junio de 2016;30(6):709-13.
10.
Bedossa P,
Poynard T.
An algorithm for the grading of activity in chronic hepatitis C.
The METAVIR Cooperative Study Group.
Hepatol Baltim Md.
agosto de 1996;24(2):289-93.
11.
Woo H,
Lee JY,
Yoon JH,
Kim W,
Cho B,
Choi BI.
Comparison of the Reliability of Acoustic Radiation Force Impulse Imaging and Supersonic Shear Imaging in Measurement of Liver Stiffness.
Radiology.
diciembre de 2015;277(3):881-6.
12.
Guzmán-Aroca F,
Reus M,
Berná-Serna JD,
Serrano L,
Serrano C,
Gilabert A,
et al.
Reproducibility of shear wave velocity measurements by acoustic radiation force impulse imaging of the liver: a study in healthy volunteers.
J Ultrasound Med Off J Am Inst Ultrasound Med.
julio de 2011;30(7):975-9.
13.
CarriĂłn JA,
Torres F,
Crespo G,
Miquel R,
GarcĂa-Valdecasas J-C,
Navasa M,
et al.
Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation.
Hepatol Baltim Md.
enero de 2010;51(1):23-34.
14.
Rigamonti C,
Fraquelli M,
Bastiampillai AJ,
Caccamo L,
Reggiani P,
Rossi G,
et al.
Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsy.
Liver Transpl.
mayo de 2012;18(5):566-76.